Cargando…
Down‐regulation of TROP‐2 Predicts Poor Prognosis of Hepatocellular Carcinoma Patients
Hepatocellular carcinoma (HCC) is one of the most common and lethal cancer types worldwide, especially in Asian countries. Genetic alterations, including hyperactivation of oncogenes and loss of expression of tumor suppressor genes, greatly contribute to the initiation and progression of HCC. Here w...
Autores principales: | Sin, Sarah T. K., Li, Yan, Liu, Ming, Yuan, Yun‐Fei, Ma, Stephanie, Guan, Xin‐Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211329/ https://www.ncbi.nlm.nih.gov/pubmed/30411086 http://dx.doi.org/10.1002/hep4.1242 |
Ejemplares similares
-
Trop2 is overexpressed in gastric cancer and predicts poor prognosis
por: Zhao, Wei, et al.
Publicado: (2015) -
Down‐regulation of POTEG predicts poor prognosis in esophageal squamous cell carcinoma patients
por: Wang, Ling, et al.
Publicado: (2018) -
Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients
por: Bing, Yuntao, et al.
Publicado: (2018) -
Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Guo-Liang, et al.
Publicado: (2012) -
High expression of TROP2 correlates with poor prognosis in pancreatic cancer
por: Fong, D, et al.
Publicado: (2008)